Outperform Recommendation Issued On CVS By Leerink Partners
Leerink Partners analyst issues OUTPERFORM recommendation for CVS on March 5, 2026 03:24PM ET. The previous analyst recommendation was Outperform.CVS was trading at $79.15 at issue of the analyst recommendation.The...








